178 related articles for article (PubMed ID: 33098492)
1. TPEN exerts selective anti-leukemic efficacy in ex vivo drug-resistant childhood acute leukemia.
Mendivil-Perez M; Velez-Pardo C; David-Yepes GE; Fox JE; Jimenez-Del-Rio M
Biometals; 2021 Feb; 34(1):49-66. PubMed ID: 33098492
[TBL] [Abstract][Full Text] [Related]
2. TPEN selectively eliminates lymphoblastic B cells from bone marrow pediatric acute lymphoblastic leukemia patients.
Mendivil-Perez M; Velez-Pardo C; Quiroz-Duque LM; Restrepo-Rincon A; Valencia-Zuluaga NA; Jimenez-Del-Rio M
Biometals; 2022 Aug; 35(4):741-758. PubMed ID: 35635647
[TBL] [Abstract][Full Text] [Related]
3. Metal chelator TPEN selectively induces apoptosis in K562 cells through reactive oxygen species signaling mechanism: implications for chronic myeloid leukemia.
Rojas-Valencia L; Velez-Pardo C; Jimenez-Del-Rio M
Biometals; 2017 Jun; 30(3):405-421. PubMed ID: 28409295
[TBL] [Abstract][Full Text] [Related]
4. TPEN Exerts Antitumor Efficacy in Murine Mammary Adenocarcinoma Through an H2O2 Signaling Mechanism Dependent on Caspase-3.
Soto-Mercado V; Mendivil-Perez M; Urueña-Pinzon C; Fiorentino S; Velez-Pardo C; Jimenez-Del-Rio M
Anticancer Agents Med Chem; 2018; 18(11):1617-1628. PubMed ID: 29697031
[TBL] [Abstract][Full Text] [Related]
5. Combinational treatment of TPEN and TPGS induces apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo.
Mendivil-Perez M; Jimenez-Del-Rio M; Velez-Pardo C
Med Oncol; 2022 May; 39(7):109. PubMed ID: 35578067
[TBL] [Abstract][Full Text] [Related]
6. TPEN induces apoptosis independently of zinc chelator activity in a model of acute lymphoblastic leukemia and ex vivo acute leukemia cells through oxidative stress and mitochondria caspase-3- and AIF-dependent pathways.
Mendivil-Perez M; Velez-Pardo C; Jimenez-Del-Rio M
Oxid Med Cell Longev; 2012; 2012():313275. PubMed ID: 23320127
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of TPEN variants to improve cancer cells selective killing capacity.
Schaefer-Ramadan S; Barlog M; Roach J; Al-Hashimi M; Bazzi HS; Machaca K
Bioorg Chem; 2019 Jun; 87():366-372. PubMed ID: 30913468
[TBL] [Abstract][Full Text] [Related]
8. Zinc Depletion by TPEN Induces Apoptosis in Human Acute Promyelocytic NB4 Cells.
Zhu B; Wang J; Zhou F; Liu Y; Lai Y; Wang J; Chen X; Chen D; Luo L; Hua ZC
Cell Physiol Biochem; 2017; 42(5):1822-1836. PubMed ID: 28750402
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CP55940 selectively induces apoptosis in Jurkat cells and in ex vivo T-cell acute lymphoblastic leukemia through H
Soto-Mercado V; Mendivil-Perez M; Jimenez-Del-Rio M; Fox JE; Velez-Pardo C
Leuk Res; 2020 Aug; 95():106389. PubMed ID: 32540572
[TBL] [Abstract][Full Text] [Related]
10. Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells.
Carraway RE; Dobner PR
Biochim Biophys Acta; 2012 Feb; 1823(2):544-57. PubMed ID: 22027089
[TBL] [Abstract][Full Text] [Related]
11. Anti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous Leukemia.
Somintara S; Leardkamolkarn V; Suttiarporn P; Mahatheeranont S
PLoS One; 2016; 11(1):e0146869. PubMed ID: 26752299
[TBL] [Abstract][Full Text] [Related]
12. Chk1 and DNA-PK mediate TPEN-induced DNA damage in a ROS dependent manner in human colon cancer cells.
Rahal ON; Fatfat M; Hankache C; Osman B; Khalife H; Machaca K; Muhtasib HG
Cancer Biol Ther; 2016 Nov; 17(11):1139-1148. PubMed ID: 27690730
[TBL] [Abstract][Full Text] [Related]
13. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
14. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
Heo SK; Noh EK; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
BMC Cancer; 2020 Dec; 20(1):1193. PubMed ID: 33276759
[TBL] [Abstract][Full Text] [Related]
15. Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species.
Fatfat M; Merhi RA; Rahal O; Stoyanovsky DA; Zaki A; Haidar H; Kagan VE; Gali-Muhtasib H; Machaca K
BMC Cancer; 2014 Jul; 14():527. PubMed ID: 25047035
[TBL] [Abstract][Full Text] [Related]
16. The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.
Spinello I; Saulle E; Quaranta MT; Pasquini L; Pelosi E; Castelli G; Ottone T; Voso MT; Testa U; Labbaye C
Haematologica; 2019 May; 104(5):973-985. PubMed ID: 30467201
[TBL] [Abstract][Full Text] [Related]
17. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.
Colado E; Alvarez-Fernández S; Maiso P; Martín-Sánchez J; Vidriales MB; Garayoa M; Ocio EM; Montero JC; Pandiella A; San Miguel JF
Haematologica; 2008 Jan; 93(1):57-66. PubMed ID: 18166786
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress and ROS-Mediated Signaling in Leukemia: Novel Promising Perspectives to Eradicate Chemoresistant Cells in Myeloid Leukemia.
Trombetti S; Cesaro E; Catapano R; Sessa R; Lo Bianco A; Izzo P; Grosso M
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671113
[TBL] [Abstract][Full Text] [Related]
19. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Zwaan CM; Kaspers GJ; Pieters R; Hählen K; Janka-Schaub GE; van Zantwijk CH; Huismans DR; de Vries E; Rots MG; Peters GJ; Jansen G; Creutzig U; Veerman AJ
Blood; 2002 Jan; 99(1):245-51. PubMed ID: 11756178
[TBL] [Abstract][Full Text] [Related]
20. Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.
Larrue C; Saland E; Vergez F; Serhan N; Delabesse E; Mansat-De Mas V; Hospital MA; Tamburini J; Manenti S; Sarry JE; Récher C
Mol Cancer Ther; 2015 Oct; 14(10):2364-73. PubMed ID: 26206337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
